Locoregional Therapy for Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1664-5553|4|3|163-164

ISSN： 2235-1795

Source： Liver Cancer, Vol.4, Iss.3, 2015-06, pp. : 163-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future

By  

Liver Cancer, Vol. 3, Iss. 1, 2014-02 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: Is there a lead-time bias?

By Huo Teh-Ia   Huang Yi-Hsiang   Chiang Jen-Huei   Wu Jaw-Ching   Lee Pui-Ching   Chi Chin-Wen   Lee Shou-Dong  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 4, 2007-01 ,pp. : 485-492

Informa Healthcare

Access to resources Recommend Favorite

Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis

By  

Liver Cancer, Vol. 5, Iss. 3, 2016-05 ,pp. : 175-189

Karger

Access to resources Recommend Favorite

Gene Therapy of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 19, Iss. 4, 2002-03 ,pp. : 324-332

Karger

Access to resources Recommend Favorite

Surgical Therapy of Hepatocellular Carcinoma

By  

Digestion, Vol. 59, Iss. 2, 1998-08 ,pp. : 78-79

Karger

Access to resources Recommend Favorite